Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ABT - ABBOTT LABORATORIES


Close
114.87
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:35 PM CET
Surgical and Medical Instrument Manufacturing : 0.39%

PREVIOUS CLOSE
CHG
CHG%

$114.87
-2.22
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 67%
Dept financing 33%
Liquidity 19%
Performance 56%
Company vs Stock growth
vs
Performance
5 Days
1.43%
1 Month
-2.58%
3 Months
-0.51%
6 Months
8.05%
1 Year
5.30%
2 Year
5.63%
Key data
Stock price
$114.87
P/E Ratio 
35.46
DAY RANGE
$112.66 - $114.87
EPS 
$3.18
52 WEEK RANGE
$101.77 - $121.64
52 WEEK CHANGE
$4.77
MARKET CAP 
197.078 B
YIELD 
1.89%
SHARES OUTSTANDING 
1.740 B
DIVIDEND
$0.55
EX-DIVIDEND DATE
07/15/2024
NEXT EARNINGS DATE
10/16/2024
BETA 
0.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,302,768
AVERAGE 30 VOLUME 
$5,214,552
Company detail
CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

Recent news